Concepedia
Statistics
Publications
26
Citations
1.2K
H-Index
18
Active since
2008
Affiliations
University of North Texas(Current)
University of North Texas Health Science Center
SignPath Pharma (United States)
Bipar
Yale University
Amalendu P. Ranjan is an author at University of North Texas specializing in nanomedicine, drug delivery, and pharmacy.
Publications per year
2008–2024
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer
Sanjay Thamake, Sangram Raut, Zygmunt Gryczyński et al. · Biomaterials · 2012 · 181 citations
Pharmacy, Oncology, Pharmacology +16
Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
Amalendu P. Ranjan, Anindita Mukerjee, Lawrence Helson et al. · Journal of Nanobiotechnology · 2012 · 129 citations · Full text
Pharmacy, Bioengineering, Pharmaceutics +17
Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Amalendu P. Ranjan, Anindita Mukerjee, Lawrence Helson et al. · PubMed · 2013 · 108 citations
Pharmacy, Oncology, Pharmacology +17
Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials
Andrew Gdowski, K. V. B. Johnson, Sunil Shah et al. · Journal of Nanobiotechnology · 2018 · 80 citations · Full text
Pharmacy, Biomedical Engineering, Pharmaceutics +17
Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy
Sanjay Thamake, Sangram Raut, Amalendu P. Ranjan et al. · Nanotechnology · 2010 · 64 citations
Pharmacy, Materials Science, Pharmaceutics +17
1–5 of 26